Sunday - December 22, 2024

Tetrahydro-1h-Pyrazino[2,1-A]isoindolylquinoline Compounds for the Treatment of Autoimmune Disease

2024-12-03

ALEXANDRIA, Virginia, Dec. 3 -- HOFFMANN-LA ROCHE INC., Little Falls, New Jersey has been assigned a patent (No. US 12157746 B2, initially filed June 3, 2019) developed by six inventors Fabian Dey, Basel, Switzerland; Hong Shen, Shanghai, China; Hongtao Xu, Shanghai, China; Hongying Yun, Shanghai, China; Ge Zou, Shanghai, China; and Wei Zhu, Shanghai, China, for "Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune disease." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Tetrahydro-1h-Pyrazino[2,1-A]isoindolylquinoline Compounds for the Treatment of Autoimmune Disease

Information Request Form

Copyright Targeted News Service 2024